Physician profile
Jad Harb
NPI 1467685677
$2,062.59
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $256 · 2021: $71.61 · 2022: $569 · 2023: $89.93 · 2024: $72.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $280.38 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $248.89 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $240.04 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.20 | 2019-2022 | |
| Abbvie INC. | $162.16 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $79.22 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $72.78 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $71.25 | 2019-2022 | |
| Grifols USA, LLC | $70.09 | 2019-2020 | |
| Genzyme Corporation | $56.70 | 2020-2022 | |
| Mylan Specialty L.P. | $55.69 | 2019-2022 | |
| Genentech USA, INC. | $52.57 | 2019 | |
| Philips North America LLC | $47.68 | 2019-2022 | |
| Electromed, INC. | $45.43 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $44.65 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $37.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $35.39 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $30.60 | 2019 | |
| Insmed, INC. | $29.56 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $26.21 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.42 | 2019-2020 | |
| Circassia INC. | $21.54 | 2019 | |
| Advanced Respiratory, INC | $20.44 | 2019 | |
| Pulmonx Corporation | $20.44 | 2019 | |
| Mayne Pharma Commercial LLC | $17.08 | 2019 | |
| United Therapeutics Corporation | $16.93 | 2019 | |
| Shire North American Group INC | $14.96 | 2019 | |
| Mallinckrodt Enterprises LLC | $14.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.07 | 2020 | |
| Gilead Sciences, INC. | $11.80 | 2019 | |
| Paratek Pharmaceuticals, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jad Harb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.